KARISA KINDY: Open Payments
NPI 1013439421 · SIMPSONVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$805 in 36 payments from 20 companies in 2025. Trend: 2023 $184 · 2024 $481 · 2025 $805
Food & beverage: $805
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $180 |
| Novo Nordisk Inc | 5 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
| PFIZER INC. | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| ABBVIE INC. | 2 | $40 |
| Eisai Inc. | 1 | $33 |
| Stryker Corporation | 1 | $30 |
| Lilly USA, LLC | 2 | $30 |
Products named: Veozah, XIFAXAN, NURTEC ODT, SHINGRIX, LEQVIO, Ozempic, Leqembi, FLOWTRIEVER CATHETER, S.
Industry payments across SC — which companies pay providers there.
